Analyst Ratings For Jack Henry & Associates
Within the last quarter, Jack Henry & Associates (NASDAQ:JKHY) has observed the following analyst ratings:
Raymond James Downgrades Jack Henry & Associates to Market Perform
Raymond James analyst John Davis downgrades Jack Henry & Associates (NASDAQ:JKHY) from Outperform to Market Perform.
Fintech Focus For December 9, 2021
One Big Thing In Fintech: With a goal of bringing DeFi technology to the masses, WonderFi has teamed up with Animal Capital to launch Money Goals.
A Bearish Sign Appears On Jack Henry & Associates’s Chart
If history is any guide, there may be trouble ahead for shares of Jack Henry & Associates (NASDAQ:JKHY). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
UBS Initiates Coverage On Jack Henry & Associates with Neutral Rating, Announces Price Target of $162
UBS analyst Rayna Kumar initiates coverage on Jack Henry & Associates (NASDAQ:JKHY) with a Neutral rating and announces Price Target of $162.
Raymond James Maintains Outperform on Jack Henry & Associates, Lowers Price Target to $174
Raymond James analyst John Davis maintains Jack Henry & Associates (NASDAQ:JKHY) with a Outperform and lowers the price target from $192 to $174.
Recap: Jack Henry & Associates Q1 Earnings
Jack Henry & Associates (NASDAQ:JKHY) reported its Q1 earnings results on Monday, November 8, 2021 at 04:00 PM.
Here's what investors need to know about the announcement.
Jack Henry & Associates Q1 EPS $1.38 Beats $1.32 Estimate, Sales $488.06M Miss $489.35M Estimate
Jack Henry & Associates (NASDAQ:JKHY) reported quarterly earnings of $1.38 per share which beat the analyst consensus estimate of $1.32 by 4.55 percent. This is a 15.97 percent increase over earnings of $1.19 per share
Earnings Scheduled For November 8, 2021
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million.